As for postmenopausal breast cancer, neither the levels of circulating IGF-1 (Jernström and Barrett-Connor, 1999) nor the IGF1 genotype appear to affect the risk (Missmer et al, 2002; DeLellis et al, 2003). Here, IGF1 is linked to breast cancer.